cardiometabolic syndrome
Recently Published Documents


TOTAL DOCUMENTS

239
(FIVE YEARS 55)

H-INDEX

27
(FIVE YEARS 2)

2022 ◽  
Author(s):  
Samaneh Soleymani ◽  
Mohammad Hossein Ayati ◽  
Mohammad Javad Mansourzadeh ◽  
Nazli Namazi ◽  
Arman Zargaran

2022 ◽  
Vol 52 ◽  
Author(s):  
Hack-Lyoung Kim ◽  
Jaehoon Chung ◽  
Kyung-Jin Kim ◽  
Hyun-Jin Kim ◽  
Won-Woo Seo ◽  
...  

2021 ◽  
pp. 1-44
Author(s):  
Soheila Abachi ◽  
Geneviève Pilon ◽  
André Marette ◽  
Laurent Bazinet ◽  
Lucie Beaulieu

Author(s):  
Sumita Mishra ◽  
Nandhini Sadagopan ◽  
Brittany Dunkerly-Eyring ◽  
Susana Rodriguez ◽  
Dylan C. Sarver ◽  
...  

2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
Q Dai ◽  
B Bose ◽  
P Li ◽  
B Liu ◽  
L Jin ◽  
...  

Abstract Background Sarcoidosis is a systemic granulomatous disease with cardiac involvement reported in 20–27% of patients [1]. Cardiac sarcoidosis (CS) can lead to atrial or ventricular arrhythmias, various conduction system disorders, heart failure or sudden cardiac death, depending on the location of myocardial involvement [2]. Previous studies have investigated the possible types of CS based on the distribution of myocardial involvement on imaging as well as the role of genetic factors [3,4]. However, there are no studies describing the clinical heterogeneity of CS patients. Purpose In order to determine if clinical clusters exist in CS, we carried out a latent class analysis (LCA) to explore potential phenotypes in a large sample of CS patients from the National Inpatient Sample (NIS). Methods We identified 848 patients with a diagnosis of CS from the NIS in 2016–2018. A LCA was performed based on comorbidities. Utilizing the Bayesian information criterion and Akaike's information criterion we divided our study population into 3 cohorts. We subsequently applied the LCA model for our study population to fit each patient into one of the 3 cohorts. Finally, we compared the clinical outcomes among the 3 groups. Results Following LCA, patients in cohort 3 were strongly associated with a cardiometabolic syndrome profile with the highest prevalence of congestive heart failure (CHF, 95.1%), chronic kidney disease (CKD, 69.7%), diabetes mellitus (68.9%), hyperlipidemia (52.5%) and obesity (45.1%). Patients in cohort 2 had an intermediate prevalence of cardiometabolic syndrome with a universal diagnosis of hypertension (100%) but with the lowest number of CHF (32.5%) patients and none with CKD. Finally, patients in cohort 1 had the least comorbidities in comparison to the other groups but there was a higher prevalence of CHF (71.7%). There was no significant difference in mortality among the 3 groups, but acute respiratory failure was the highest in cohort 3. However, ventricular arrhythmias were more prevalent in cohort 1 patients (Table). Conclusion We identified 3 different types of CS based on their clinical phenotype. The clinical outcomes varied among the cohorts with ventricular arrhythmias being the most prevalent in patients with the least cardiometabolic comorbidities. FUNDunding Acknowledgement Type of funding sources: None.


2021 ◽  
Vol 142 ◽  
pp. 112017
Author(s):  
Abodunrin Adebayo Ojetola ◽  
Wale Johnson Adeyemi ◽  
Ubong Edem David ◽  
Temitayo Olabisi Ajibade ◽  
Olumuyiwa Abiola Adejumobi ◽  
...  

2021 ◽  
Author(s):  
Hanna Szmygin ◽  
Joanna Szydełko ◽  
Beata Matyjaszek-Matuszek

Sign in / Sign up

Export Citation Format

Share Document